In clinical practice, BRCA1/2 are the most widely tested genes, particularly for breast cancer patients diagnosed at young age, with triple negative breast cancer (TNBC), or have a significant family history of breast, ovarian, or other related cancers [3]. This evidence concerns the gene BRCA1 and breast carcinoma.